Predict your next investment

INTERNET | Internet Software & Services / Healthcare

See what CB Insights has to offer


Acquired | Acquired

About Artemetrx

Artemetrx offers a data aggregation engine that combines behavioral, medical, dental, vision, lab, and prescription drug data to provide a view of health-related utilization and expenditures. This Clinical Business Intelligence Engine transforms the standard health data into actionable information that is accessible through a web-based decision support tool. In addition, Artemetrx offers a suite of clinical intervention programs that leverage the integrated data to improve care and control costs. These programs range from pharmacy-centric programs to population health programs.In March 2012, Artemetrx was acquired by Pharmaceutical Strategies Group. The valuation of Artemetrx was undisclosed. Other terms of the deal were not released.

Artemetrx Headquarter Location

515 Maryland Way Suite 216

Brentwood, Tennessee, 37027,

United States


Latest Artemetrx News

New Product Launch: Pharmaceutical Strategies Group Launches Artemetrx Rebate Monitor

Sep 23, 2021

Improved oversight of PBM rebates via Artemetrx Rebate Monitor protects the financial interests of health plans Download September 23, 2021 11:02 AM Eastern Daylight Time DALLAS--( BUSINESS WIRE )--Artemetrx Rebate Monitor accelerates health plan ability to identify and resolve variances in pharmacy benefit manager (PBM) rebates. Industry insiders designed the newly unveiled tool to revolutionize the approach to rebate guarantees. Artemetrx Rebate Monitor provides insights to health plans on the adherence to contract terms by the PBM for rebate guarantees. The crucial new tool protects a health plan’s bottom line and relationship with their PBM. “Rebates are the most critical component of a PBM contract,” said Beth Hebert-Silvia, RPh, Senior Vice President and Health Plan Practice Leader of PSG. “Timely rebate monitoring means health plans can protect financial interests, improve client satisfaction, and increase pharmacy market share.” Health plans are tapping into Artemetrx Rebate Monitor because it completely overhauls the complex work required to review PBM paid rebates. Artemetrx Rebate Monitor transforms intricate contract terms, conditions, and guarantees into configurable rules applied to actual pharmacy claims data each month. Artemetrx Rebate Monitor protects the financial interests of health plans via improved rebate oversight. Innovative features include: Dashboards and reporting that quickly identify underperforming rebates by channel or formulary Independent interpretation and calculation of expected rebates by channel Monthly claims ingestion and projection of expected rebates Quarterly ingestion of PBM actual data and ongoing updates Detailed variance reporting between projected and actual rebates paid Access via the Artemetrx web-based software to your data, 24/7 “The speed and efficiency of Artemetrx Rebate Monitor create extraordinary new opportunities to ensure maximum value from rebates,” said Michael Lonergan, RPh, President of PSG. “Innovating is core to our mission. Artemetrx Rebate Monitor is the latest achievement in our more than 25-year legacy of relentless client advocacy.” Artemetrx is a proprietary industry-leading web-based software for integrated drug management developed by Pharmaceutical Strategies Group (PSG), an EPIC company. Rebate Monitor is the latest in a series of innovations on the Artemetrx platform. Learn more about how Artemetrx Rebate Monitor is irreversibly shaking up the way rebates are managed: About PSG Pharmaceutical Strategies Group, an EPIC company, relentlessly advocates for clients as they navigate complex and ever-changing drug cost management challenges. PSG’s innovative drug management solutions, including the proprietary data and analytics platform, Artemetrx, deliver actionable insights with exceptional financial and clinical value. PSG functions as a strategic partner through industry-leading intelligence and technologies to realize billions of dollars in drug cost savings for clients every year. Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Artemetrx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Artemetrx is included in 1 Expert Collection, including Value-Based Care & Population Health.


Value-Based Care & Population Health

645 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.